Key facts
- Notable investors include Tech Incubator Program for Startup, FuturePlay.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for A.I. Flow
- ·The full record, as it builds
Funding rounds
No funding rounds for A.I. Flow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About A.I. Flow
Developer of a wearable drug delivery device and data-driven glucose management system designed for the treatment of diabetes. The company combines a patch-type insulin infusion unit with a reusable actuator module to increase insulin delivery capacity and injection speed, enabling diabetes patients and healthcare providers to streamline insulin administration.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2025
- Website
- aiflowinc.com/
- Ownership
- Privately Held (backing)
A.I. Flow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in A.I. Flow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on A.I. Flow in its N-PORT filings yet. We sweep new filings monthly.